HIV-1 Tat induces tyrosine phosphorylation of p125(FAK) and its association with phosphoinositide 3-kinase in PC12 cells

AIDS

Volumn 12, Issue 11, 1998, Pages 1275-1284

  Milani, Daniela ^a   Mazzoni, Meri ^a   Zauli, Giorgio ^a   Mischiati, Carlo ^a   Gibellini, Davide ^b   Giacca, Mauro ^c   Capitani, Silvano ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Focal adhesion kinase; HIV 1; PC12 cells; Phosphoinositide 3 kinase; Signal transduction; Tat

Indexed keywords

COMPLEMENTARY DNA; FOCAL ADHESION KINASE; INOSITOL TRISPHOSPHATE 3 KINASE; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; GENE MUTATION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 0032581714     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199811000-00008     Document Type: Article

References (44)

1. Jones KA, Peterlin MB: Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 1994, 63:717-743.
2. Ensoli B, Barillari C, Zaki Salahuddin S, Gallo RC, Wong-Stall F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990, 345:84-86.
3. Ensoli B, Buonaguro L, Barillari C, et al.: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 tat protein on cell growth and viral transactivation. J Virol 1993, 67:277-287.
4. Westendorp MO, Frank R, Ochsenbauer C, et al.: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995, 375:497-500.
5. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB: Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995, 268:229-231.
6. + T lymphocytes. J. Immunol 1996, 157:2216-2224.
7. McCloskey TW, Ott M, Tribble E, et al.: Dual role of HIV Tat in regulation of apoptosis in T cells. J Immunol 1997, 158:1014-1025.
8. Sabatier J, Vives E, Mabrouk K, et al.: Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 1991, 65:961-967.
9. Kolson DL, Buchalter J, Collman R, et al.: HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures; RGD sequence dependence. AIDS Res Hum Retrovirol 1993, 9:677-685.
10. Philippon V, Vellutini C, Gambarelli D, et al.: The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 1994, 205:519-529.
11. Magnuson DSK, Knudsen BE, Geiger JD, Brownstone RM, Nat AB: Human immunodeficiency virus type 1 Tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995, 37:373-380.
12. Orsini MJ, Debouch CM, Webb CL, Lysko PG: Extracellular human immunodeficiency virus type 1 Tat protein promotes aggregation and adhesion of cerebellar neurons. J Neurosci 1996, 16:2546-2552.
13. Nath A, Psooy K, Martin C et al.: Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996, 70:1475-1480.
14. Mann DA, Frankel AD: Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J 1991, 10:1733-1738.
15. Buonaguro L, Barillari G, Chang HK, et al.: Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokine. J Virol 1992, 66:7159-7167.
16. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M: Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for HIV-1 induced hematopoietic suppression. Blood 1992, 80:3036-3043.
17. Scala G, Ruocco MR, Ambrosino C, et al.: The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 tat protein. J Exp Med 1994, 179:961-971.
18. Westendorp MO, Li-Weber M, Frank RW, Krammer PH: Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 1994, 68:4177-4185.
19. Sharma V, Knobloch TJ, Benjamin D: Differential expression of cytokine genes in HIV-1 tat transfected T and B cell lines. Biochem Biophys Res Commun 1995, 208:704-713.
20. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, McCord JM: Tat protein of HIV-1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA 1993, 90:7632-7636.
21. Milani D, Mazzoni M, Borgatti P, Zauli G, Cantley L, Capitani S: Extracellular human immunodeficiency virus type-1 (HIV-1) Tat protein activates PI-3 Kinase in PC12 neuronal cells. J Biol Chem 1996, 271:22961-22964.
22. Conant K, Ma M, Nath A, Major E: Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-κB binding and protein kinase C activity in primary human astrocytes. J Virol 1996, 70:1384-1391.
23. Brake DA, Debouck C, Biesecher G: Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein. Tat. J Cell Biol 1990, 111:1275-1281.
24. Barillari G, Gendelman R, Gallo RC, Ensoli B: The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same types by using integrin receptors recognizing RGD amino acid sequence. Proc Natl Acad Sci USA 1993, 90:7941-7945.
25. Weeks BS, Desai K, Loewenstein PM, et al.: Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. J Biol Chem 1993, 268:5279-5284.
26. Albini A, Soldi R, Giunciuglio D, et al.: The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-KDR receptor on vascular endothelial cells. Nature Med 1996, 2:1371-1375.
27. FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 1992, 89:5192-5196.
28. FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 1992, 71:891-894.
29. Giancotti FG: Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 1997, 9:691-700.
30. Greene LA, Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976, 3:2424-2428.
31. Milani D, Zauli G, Neri I. M, Marchisio M, Previati M, Capitani S: Influence of the human immunodeficiency virus type 1 tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J Gen Virol 1993, 74:2587-2594.
32. Demarchi F, d'Adda di Fagagnana F, Falaschi A, Giacca M: Activation of transcription factor NF-κB by the Tat protein of human immunodeficiency virus type 1. J Virol 1996, 70:4427-4437.
33. Valvatne H, Szilvay AM, Heiland DE: A monoclonal antibody defines a novel HIV type 1 Tat domain involved in trans-cellular trans-activation. AIDS Res Hum Retroviruses 1966, 12:611-619.
34. Rasouly D, Shavit D, Zuniga R, et al.: Staurosporin induces neurite outgrowth in neuronal hybrids (PC12EN) lacking NGF receptors. J Cell Biochem 1996, 62:356-371.
35. Panayotou C, Waterfield MD: Phosphatidyl-inositol 3-kinase: a key enzyme in diverse signalling processes. Trends Cell Biol 1992, 2:358-370.
36. Leahy DI, Aukhil I, Erickson HP: A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 1996, 84:155-164.
37. Hayman M, Arbuthnott C, Harkiss G: Neurotoxicity of peptide analogues of the transactivating protein tat from maedi-visna virus and human immunodeficiency virus. Neuroscience 1993, 53:1-6.
38. Weeks BS, Lieberman DM, Johnson B: Neurotoxicity of the human immunodeficiency virus type 1 Tat transactivator in PC12 cells requires the Tat amino acid 49-58 basic domain. J Neurosci Res 1995, 42:34-40.
39. Re MC, Furlini C, Vignali M, et al.: Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J Acquir Immune Defic Syndr 1995, 10:408-416.
40. Merrill JE, Chen ISY: HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 1991, 5:23921-23927.
41. Prince RW, Brew BJ, Sidtis JJ, Rosenblum MP, Scheck AC, Cleary P: The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988, 239:586-592.
42. Frisch SM, Ruoslahti E: Integrin and anoikis. Curr Opin Cell Biol 1997, 9:701-706.
43. Hatai M, Hashi H, Mogi A, Soga H, Yokota J, Yaoi Y: Stimulation of tyrosine- and serine-phosphorylation of focal adhesion kinase in mouse 3T3 cells by fibronectin and fibroblast growth factor. FEBS Lett 1994, 350:113-116.
44. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.